Shire PLC (SHP) PT Lowered to GBX 5,200
Shire PLC (LON:SHP) had its price target lowered by equities researchers at HSBC from GBX 5,250 ($68.53) to GBX 5,200 ($67.88) in a research report issued to clients and investors on Wednesday. The firm presently has a ” hold” rating on the biopharmaceutical company’s stock. HSBC’s price objective points to a potential upside of 2.75% from the company’s current price.
A number of other equities research analysts also recently issued reports on SHP. Royal Bank Of Canada restated an “outperform” rating on shares of Shire PLC in a report on Wednesday, June 15th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a GBX 6,300 ($82.23) price objective (up from GBX 5,600 ($73.10)) on shares of Shire PLC in a research note on Monday, August 1st. Jefferies Group boosted their price objective on shares of Shire PLC from GBX 6,050 ($78.97) to GBX 6,600 ($86.15) and gave the stock a “buy” rating in a research note on Wednesday, August 3rd. Morgan Stanley reiterated an “overweight” rating and set a GBX 5,600 ($73.10) price objective on shares of Shire PLC in a research note on Friday, June 3rd. Finally, BNP Paribas reiterated an “outperform” rating and set a GBX 5,700 ($74.40) price objective on shares of Shire PLC in a research note on Monday, June 6th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of GBX 5,828 ($76.07).
Shire PLC (LON:SHP) opened at 5006.00 on Wednesday. The company has a 50 day moving average of GBX 4,985.30 and a 200-day moving average of GBX 4,508.27. The stock’s market capitalization is GBX 34.18 billion. Shire PLC has a 52-week low of GBX 2,707.19 and a 52-week high of GBX 5,377.00.
The business also recently declared a dividend, which will be paid on Friday, October 7th. Investors of record on Thursday, September 8th will be issued a GBX 3.51 ($0.05) dividend. The ex-dividend date is Thursday, September 8th. This represents a yield of 0.07%.
About Shire PLC
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Receive News & Stock Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related stocks with our FREE daily email newsletter.